Global expansion Sterigenics is actively expanding its U.S. and international footprint with new facilities, including a recent x-ray sterilization facility in the Southeast United States and expanded offices in Mississauga, Canada, signaling ongoing capacity growth and new regional service capabilities to target local medical device manufacturers and pharma clients.

Technology mix The company utilizes multiple sterilization modalities (gamma, ethylene oxide, electron beam, X-ray, nitrogen dioxide) supported by a tech stack including SAP, Microsoft Azure, Power BI and SQL Server, offering cross-modality expertise to upsell integrated sterilization solutions and data-driven process optimization for customers seeking flexible, compliant sterilization outsourcing.

Regulatory readiness Public coverage highlights regulatory scrutiny and community concerns around ethylene oxide emissions, suggesting a sales opportunity to position Sterigenics as a trusted, compliant partner with strong safety and environmental controls to reassure customers seeking compliant, low-risk outsourcing options.

Global network With a 48-facility footprint across 13 countries, Sterigenics can offer redundancy and regional coverage for global manufacturers, enabling conversations around continent-level sterilization strategies, supply chain resilience, and 24/7 capacity planning for high-volume medical device and pharmaceutical clients.

Financial signal Revenue growth reports indicate solid demand growth and a sizable scale opportunity within the upper mid-market segment, presenting a compelling case for targeting mid-to-large medical device and pharma contract manufacturers seeking reliable outsourcing partners with multi-modal capabilities and scalable capacity.